Target intelligence / Profile preview

Chromosome 18 open reading frame 32 (C18orf32)

Target
C18orf32
Molecular classification
Other (Uncharacterised small protein family[5][8]), Putative signal transducer (per some annotations, but function remains poorly understood[3][5][8])
01

Overview

Chromosome 18 open reading frame 32 (C18orf32) encodes a small 76-amino-acid protein localized primarily to the endoplasmic reticulum and lipid droplets in a wide range of human tissues[4][10][11][5]. It is implicated in the positive regulation of the canonical NF-kappa-B signaling pathway and may be involved in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, which are important for membrane protein anchoring[1][5][3]. The gene is associated with rare congenital disorders linked to GPI anchor biosynthesis defects[3]. However, the specific molecular function remains poorly characterized, and it is not currently considered a validated or canonical therapeutic target such as a receptor, enzyme, transporter, or transcription factor[3][5][11]. Its role may be supportive or regulatory rather than being a direct target for drugs. Its alternative names reflect its protein family classification and its suspected—yet unconfirmed—role in NF-kappa-B pathway activation[3][1][5].

Other names
UPF0729 protein C18orf32FLJ23458Putative NF-kappa-B-activating protein 200GPIBD25Putative NFkB activating protein
02

Biological functions

Positive regulation of canonical NF-kappa-B signal transduction[3][5][11]Possible involvement in GPI-anchor biosynthesis[1]
03

Disease associations

Glycosylphosphatidylinositol biosynthesis defect 25[3][7]Dyggve-Melchior-Clausen Disease[3]Macrocytic anemia (noted in gene fusion context with RPL17)[7]

Beyond the preview

Go deeper on Chromosome 18 open reading frame 32 (C18orf32).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chromosome 18 open reading frame 32 (C18orf32).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call